| # | Drug | Count |
|---|---|---|
| 0 | BEVACIZUMAB | 7 |
| 1 | ABIRATERONE ACETATE | 5 |
| 2 | CABAZITAXEL | 5 |
| 3 | DENOSUMAB | 5 |
| 4 | ENZALUTAMIDE | 5 |
| 5 | RADIUM RA 223 DICHLORIDE | 5 |
| 6 | BROLUCIZUMAB | 3 |
| 7 | ADALIMUMAB | 2 |
| 8 | DILTIAZEM HYDROCHLORIDE | 2 |
| 9 | IBUPFROFEN | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | METEX | 1 | 0.0026 |
| 1 | CABAZITAXEL | 5 | 0.0014 |
| 2 | RADIUM RA 223 DICHLORIDE | 5 | 0.0010 |
| 3 | BROLUCIZUMAB | 3 | 0.0008 |
| 4 | BALANCED SALT SOLUTION | 1 | 0.0008 |
| 5 | LOTEPREDNOL ETABONATE | 2 | 0.0004 |
| 6 | REPOSITORY CORTICOTROPIN | 1 | 0.0002 |
| 7 | MINOCYCLINE HYDROCHLORIDE | 1 | 0.0002 |
| 8 | ABIRATERONE ACETATE | 5 | 0.0001 |
| 9 | FARICIMAB | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Adrenocorticotropic Hormone [EPC] | 1 | 0.0011 |
| 1 | Androgen Receptor Inhibitor [EPC] | 5 | 0.0001 |
| 2 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 9 | 0.0000 |
| 3 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |
| 4 | Dipeptidyl Peptidase 4 Inhibitor [EPC] | 1 | 0.0000 |
| 5 | RANK Ligand Inhibitor [EPC] | 5 | 0.0000 |
| 6 | Prostaglandin Analog [EPC] | 2 | 0.0000 |
| 7 | Epidermal Growth Factor Receptor Antagonist [EPC] | 1 | 0.0000 |
| 8 | Hepatitis C Virus NS5A Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Copper-containing Intrauterine Device [EPC] | 1 | 0.0000 |